Lipella Pharmaceuticals Inc. Cash and Cash Equivalents
Lipella Pharmaceuticals Inc. (LIPO) had Cash and Cash Equivalents of $1.86 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2025-11-14
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $1.86M.
- 2025-06-30: Cash and Cash Equivalents, at Carrying Value $2.78M.
- 2025-03-31: Cash and Cash Equivalents, at Carrying Value $4.23M.
- 2024-12-31: Cash and Cash Equivalents, at Carrying Value $2.18M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2025-09-30 | $1.86M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $2.78M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $4.23M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $2.18M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $1.35M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.19M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $2.11M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $3.29M 10-K · filed 2025-03-28 |
| 2023-09-30 | $2.41M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $3.11M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $4.02M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $5.12M 10-K · filed 2024-02-27 |
| 2021-12-31 | $1.41M 10-K · filed 2023-03-31 |